Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol + ibuprofen for pain relief in primary dysmenorrhea
2015-002446-31Phase 3Active
- Sponsor
- Farmalíder
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ibuprofen and acetaminophen in primary dysmenorrhea (PD) (4 arms), sponsored by Farmalíder. Primary endpoints: Pain intensity difference over 0 to 6 hours and Total pain relief over 0 to 6 hours. Started Jul 2015; status: active.
02
Drugs
ibuprofenacetaminophen
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on 2015-002446-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002446-31.